Literature DB >> 12560231

A unique atrial primary cardiac lymphoma mimicking myxoma presenting with embolic stroke: a case report.

Michael M Quigley1, Eric Schwartzman, Pamela D Boswell, Rebecca L Christensen, Lisa A Gleason, Robert W Sharpe, Thomas A D'Amato.   

Abstract

An immunocompetent 29-year-old male presented with an embolic stroke from an unusual primary cardiac lymphoma. The cardiac lesion consisted of a polypoid, left atrial, mural fibrin thrombus with anaplastic tumor cells lining the surface of the clot. Histologic, immunophenotypic, and molecular characterizations were consistent with a diagnosis of CD30+ large B-cell lymphoma with anaplastic cytology. While tumor emboli from invasive primary cardiac lymphomas have been reported, this noninvasive fibrin thrombus-associated lymphoma appears to be unique and previously unreported.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560231     DOI: 10.1182/blood-2002-08-2550

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Cardiac tamponade and paroxysmal third-degree atrioventricular block revealing a primary cardiac non-Hodgkin large B-cell lymphoma of the right ventricle: a case report.

Authors:  Zied Frikha; Leila Abid; Dorra Abid; Souad Mallek; Imed Frikha; Mohamed Abdennadher; Noomen Rekik; Samir Kammoun
Journal:  J Med Case Rep       Date:  2011-09-05

2.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

3.  Primary testicular lymphoma with cardiac involvement in an immunocompetent patient: case report and a concise review of literature.

Authors:  Saurabh Dahiya; Wei B Ooi; Jaya Mallidi; Senthil Sivalingam; Richard Steingart
Journal:  Rare Tumors       Date:  2012-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.